|
|
|||||||||||
EDITORIALS |
Health Services Research Department, Institute of Psychiatry, Kings College London, London, UK
Correspondence: Dr Louise Howard, PO Box 29, Health Services Research Department, Institute of Psychiatry, Kings College London, London, De Crespigny Park, London SE5 8AF, UK. E-mail: l.howard{at}iop.kcl.ac.uk
|
|
ABSTRACT |
|---|
|
|
|---|
|
|
INTRODUCTION |
|---|
|
|
|---|
|
|
EFFECT OF PREFERENCES ON OUTCOME |
|---|
|
|
|---|
There is some evidence to suggest that patient preferences do not affect outcome. For example, a study comparing day hospital and in-patient treatment for rehabilitation of alcohol-dependent patients found no significant differences in relapse or psychosocial outcomes between individuals with a preference for one of the treatment settings (who selected their treatment) and those without such a preference (who were randomised) (McKay et al, 1995). However, it is difficult to draw conclusions from this study as follow-up rates were very low, ranging from 10% to 70% in the different treatment settings. Similarly, a study that compared cognitivebehavioural therapy, non-directive counselling and general practitioner care found no significant differences in outcome (assessed by Beck Depression Inventory scores) between participants who were randomised to each treatment and those who received their preferred treatment (Ward et al, 2000). However, all outcomes were self-rated, and a conservative approach to data analysis was adopted by using the last observation carried forward. Chilvers et al (2001) randomised patients with major depression to generic counselling or antidepressant treatment in primary care, and investigated the effect of patient preference by offering a choice of treatment to the patients who were not randomised. They found that patients who chose counselling did better than those who were randomised to it, although the power of the study for detecting interactions was low. A recent systematic review of the effect of patient and physician intervention preferences on randomised trials found some evidence that patient preferences influence outcome in a proportion of trials, but the evidence for moderate or large preference effects was much weaker in large trials and after accounting for baseline differences (King et al, 2005). Therefore these studies do not demonstrate conclusively any consistent effect of preference on outcome, but they do show that preferences exist and that the characteristics of patients who have preferences may differ from those of patients who consent to randomisation.
Strong patient preferences result in patients refusing to consent to enter a trial and undergo randomisation. This leads to bias, as the absence of these patients may restrict generalisation of the findings and may weaken the external validity of the results (Torgerson & Sibbald, 1998; King et al, 2005). If patients with strong preferences are recruited and randomised, and it is not possible for them to be blinded to treatment, as is often the case in complex interventions in psychiatry, participants who are not randomised to their treatment of choice may be disappointed and suffer from resentful demoralisation (Bradley, 1996), which has implications for compliance, whereas those who are randomised to their preferred treatment may have a better outcome irrespective of the efficacy of the intervention.
The patient preference RCT paradigm or comprehensive cohort design (Brewin & Bradley, 1989) has been proposed as an alternative to the conventional RCT. Patients with treatment preferences are allowed their desired treatment without randomisation and those who do not have particular preferences are individually randomised in the usual way.
Treatment trials that include patients who are not willing to be randomised allow trialists to estimate the representativeness of the randomised sample. If randomised patients resemble non-randomised patients, the patient preference trial provides greater evidence of the external validity of the trial results. The analysis should also include at least one comparison between the two randomised arms alone, and therefore the power calculation will need to take this into consideration at the planning stage. The sample size is therefore larger than in a conventional trial. The randomised component must be as large as a standard RCT, and the number of non-randomised patients must be sufficient to allow comparison of the effect of each treatment for individuals who express a preference for that treatment with the effect for those who do not, and also comparison of individuals who are willing to be randomised and those who are not. This is a reflection of the fact that the sample size must be large enough to allow interactions between treatment and prognostic factors to be investigated (Schmoor et al, 1996). Analyses that include the non-randomised groups should be treated as observational studies, with known confounding factors adjusted for in the analysis (Torgerson & Sibbald, 1998). The use of randomised status (agreeing to randomisation or not) as a covariate might also be helpful (Olschewski & Scheurlen, 1985).
|
|
LIMITATIONS |
|---|
|
|
|---|
Second, patient preferences may change over time, both during the trial and subsequently. It is also unlikely that patients make decisions completely independently; clinicians are likely to play a part in the final decision.
Finally, it is likely to be difficult to determine how many patients will choose to enter each arm of the trial, and funding bodies may be reluctant to accept estimates of the cost and duration of the trial without the results of a pilot study specifically designed to elicit this type of information.
|
|
ADVANTAGES |
|---|
|
|
|---|
Collection of data on patient preferences may be useful to clinicians, and it may indicate whether a particular intervention is effective even in patients who are not highly motivated. For example, Moffett et al (1999) found that simple exercise classes could lead to long-term improvements in individuals with back pain who had not had a strong preference for the intervention. They asked patients what their preferences were before allocating them at the start of the trial. This had advantages over the usual patient preference design, as it demonstrated that preferences did not have an impact on outcome without needing the larger sample size that would have been necessary for a patient preference RCT.
|
|
ALL PATIENTS HAVE PREFERENCES |
|---|
|
|
|---|
More radically, Chalmers (1997) has challenged the bases of treatment preferences. He suggests that there is a widespread belief that new treatments are likely to be superior to existing alternatives. Patients therefore need to be given reliable information by clinicians and researchers, which would help to increase the proportion of well-informed people with no strong preferences who would thus be eligible to participate in randomised treatments.
In conclusion, collection of data on patient preferences may prove to be useful when evaluating mental health services. It may be part of a comprehensive cohort study examining the external validity of the population in an RCT, it may be part of an investigation of the effect of preferences on outcome, or it may be an investigation of patient choices, but all of these are important preference questions. Patient preference trials have been neglected in psychiatric research, but patient preference RCTs may prove to be a useful paradigm, and data on patient preferences are clearly an important part of mental health services research.
|
|
ACKNOWLEDGMENTS |
|---|
|
|
|---|
|
|
REFERENCES |
|---|
|
|
|---|
Brewin, C. R. & Bradley, C. (1989) Patient preferences and randomised clinical trials. BMJ, 299, 313 315.[Medline]
Chalmers, I. (1997) What is the prior
probability of a proposed new treatment being superior to established
treatments? BMJ, 314, 74
75.
Chilvers, C., Dewey, M., Fielding, K., et al
(2001) Antidepressant counselling for treatment of major
depression in primary care: randomised trial with patient preference arms.
BMJ, 322, 772
784.
King, M., Nazareth, I., Lampe F., et al
(2005) Impact of participant and physician intervention
preferences on randomized trials a systematic review.
JAMA, 293, 1089
1099.
McKay, J. R., Alterman, A. I., McLellan, T., et al (1995) Effect of random versus non-random assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics. Journal of Consulting and Clinical Psychology, 63, 70 78.[CrossRef][Medline]
Moffett, J. K., Torgerson, D., Bell-Syer, S., et al
(1999) Randomised controlled trial of exercise for low back
pain: clinical outcomes, cost and preferences. BMJ,
319, 279
283.
Olschewski, M. & Scheurlen, H (1985) Comprehensive cohort study: an alternative to randomised consent design in a breast preservation trial. Methods of Information in Medicine, 24, 131 134.[Medline]
Schmoor, C., Olschewski, M. & Schumacher, M. (1996) Randomised and non-randomised patients in clinical trials: experiences with comprehensive cohort studies. Statistics in Medicine, 15, 263 271.[CrossRef][Medline]
Torgerson, D. J., & Sibbald, B. (1998)
Understanding controlled trials: what is a patient preference?
BMJ, 316, 360
364.
Torgerson, D. J., Klaber-Moffett, J. & Russell, I. T. (1996) Patient preferences in randomised trials: threat or opportunity? Journal of Health Services Research and Policy, 1, 194 197.
Ward, E., King, M., Lloyd, M., et al
(2000) Randomised controlled trial of non-directive directive
counselling, cognitivebehavioural therapy, and usual general
practitioner care for patients with depression. I. Clinical effectiveness.
BMJ, 321, 1383
1391.
Received for publication October 25, 2004. Revision received May 10, 2005. Accepted for publication June 29, 2005.
Related articles in BJP:
This article has been cited by other articles:
![]() |
C. Abderhalden, I. Needham, T. Dassen, R. Halfens, H.-J. Haug, and J. E. Fischer Structured risk assessment and violence in acute psychiatric wards: randomised controlled trial The British Journal of Psychiatry, July 1, 2008; 193(1): 44 - 50. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |